Strata Skin Sciences (NSDQ:SSKN) said it has reached an agreement with an “internationally acclaimed health institution” giving Strata an exclusive license to treat vitiligo using its Xtrac excimer laser. In a novel treatment for vitiligo, the excimer laser incrementally increases the light emitted in the UVB range to restore pigmentation to skin areas affected with […]
Strat Skin Sciences wins FDA nod for Multi-Micro Dose excimer laser tip
Strata Skin Sciences (NSDQ:SSKN) said yesterday it won FDA 510(k) clearance for the Multi-Micro Dose tip designed for use with its Xtrac 308nm excimer laser. The newly cleared tip is indicated for use in conjunction with the Horsham, Penn.-based company’s Xtrac laser system to filter narrow band UVB light at delivery, intended to individualize non-blistering doses […]
Strata Skin Sciences raises $17m, refreshes exec roster
Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing and announced a number of changes to its executive roster, including an incoming CEO, new board chair and new chief financial officer. The Horsham, Penn.-based company said that the $17 million round of financing was led by Accelmed Growth Partners […]
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
Strata Skin Sciences raises $17m, taps Rafaeli as CEO
Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing, and that investor Dr. Dolev Rafaeli is slated to take over as interim CEO, with former chief exec Frank McCaney taking the role of interim CFO. In the sale, the Horsham, Penn.-based company said it floated 15.7 million shares of […]
Strata Skin Sciences to explore ‘strategic alternatives’
Strata Skin Sciences (NSDQ:SSKN) said today that its board of directors has begun a process to explore and review “strategic alternatives” focused on improving shareholder value, which could include a sale of the company or other transactions. The Horsham, Penn.-based company said that as part of its exploration of strategic alternatives, it is in the process […]
FDA details possible regulatory paths for Strata Sciences Optimal Dosing Tech
Strata Skin Sciences (NSDQ:SSKN) said this week it received a response letter from the FDA concerning possible 510(k) clearance paths for its Optimal Dosing Technology initially designed for treating psoriasis, vitiligo and other skin conditions. The Horsham, Penn.-based said the federal watchdog proposed 2 alternative paths, the 1st of which would require a clinical trial to […]
Report: Trump considers ex-Mela Sciences CEO Gulfo for FDA chief
A name familiar to the medical device industry has surfaced as a possible nominee to lead the FDA: the Trump administration is reportedly mulling Dr. Joseph Gulfo, the former CEO of Mela Sciences (now Strata Skin Sciences (NSDQ:SSKN)), for FDA commissioner. Dr. Stephen Ostroff is leading the federal safety watchdog on an interim basis, after the resignation of […]
Analogic CEO Green steps away | Personnel Moves Nov 4, 2016
Analogic (NSDQ:ALOG) said late last month its prez and CEO James Green has stepped away from his position to pursue other opportunities. Company director and former Enovate Medical exec chair and CEO Dr. Fred Parks has been named to take over Green’s position. “Jim Green led Analogic during a period of meaningful development and growth, and […]
Strata Skin Sciences, formerly Mela Sciences, restructures debt
Strata Skin Sciences (NSDQ:SSKN), previously known as Mela Sciences, said today it entered into a $12 million debt restructuring agreement, led by MidCap Financial Trust. The 1st tranche of $10.5 million from the credit facility was drawn on December 30 last year to repay $10 million principal amount of short-term senior secured promissory notes, plus […]
Mela Sciences, no more; Company rebrands as Strata Skin Science
Mela Sciences (NSDQ:MELA) said today it is changing its corporate name to Strata Skin Sciences, effective January 5 next year. The shift is being made to reflect the company’s focus on dermatology and a broad range of conditions, according to CEO Michael Stewart. “Our June 2015 Xtrac acquisition has expanded the dermatological opportunities that the […]
MassDevice Network
@MassDevice
LinkedIn
YouTube